AVADEL PHARMACEUTICALS PLC Financial Ratios
AVDL / Health Care|FY2024 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2024 SEC 10-K data.
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2024)
Return on Equity
-66.1%
Profit Margin
-28.9%
Net Income / Revenue
Asset Turnover
1.03
Revenue / Total Assets
Equity Multiplier
2.22
Total Assets / Equity
Composite: -66.1% (reported: -66.1%)
Profitability
Liquidity
Current Ratio
2.75
Quick Ratio
2.33
Solvency
Interest Coverage
-4.33
Efficiency
Asset Turnover
1.03
Inventory Turnover
0.75
Days Sales Outstanding
74 days
As of FY2024 · SEC 10-K · Updated Feb 28, 2026
Earnings Quality
Accrual Ratio
-1.2%
+18.1pp YoY
Earnings are roughly in line with operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.